In conclusion, we demonstrated that Kif4A expression in pretreated biopsy specimens is negatively correlated with nCRT response in patients with advanced CRC and that Kif4A regulates the sensitivity of CRC cells to chemotherapeutic drugs by regulating DDR. Here, KIF4A is linked to colorectal carcinoma.